| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JSS.2007.02.022 |
| P698 | PubMed publication ID | 17574036 |
| P2093 | author name string | Bryan A Whitson | |
| Michael A Maddaus | |||
| Todd A Kellogg | |||
| Henry Buchwald | |||
| Daniel B Leslie | |||
| Sayeed Ikramuddin | |||
| Charles J Billington | |||
| P433 | issue | 1 | |
| P304 | page(s) | 31-39 | |
| P577 | publication date | 2007-07-01 | |
| P1433 | published in | Journal of Surgical Research | Q15763329 |
| P1476 | title | Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study. | |
| P478 | volume | 141 |
| Q31154713 | A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations |
| Q42253837 | A numerical scale to assess the outcomes of metabolic/bariatric surgery (NOMS) |
| Q47177201 | A proteomic analysis of excreted and circulating proteins from obese patients following two different weight-loss strategies. |
| Q37697012 | A review of weight loss following Roux-en-Y gastric bypass vs restrictive bariatric surgery: impact on adiponectin and insulin |
| Q37427308 | Adiposopathy and bariatric surgery: is 'sick fat' a surgical disease? |
| Q36134542 | All bariatric surgeries are not created equal: insights from mechanistic comparisons |
| Q36533912 | Association of ghrelin receptor promoter polymorphisms with weight loss following Roux-en-Y gastric bypass surgery |
| Q34453612 | Bariatric surgery and diabetes: who should be offered the option of remission? |
| Q85888200 | Changes in GIP gene expression following bariatric surgery |
| Q37812028 | Changes in Ghrelin Levels Following Bariatric Surgery: Review of the Literature |
| Q34824005 | Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review |
| Q34824270 | Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery |
| Q30391329 | Changes in neurohormonal gut peptides following bariatric surgery |
| Q51402743 | Comparison of serum and salivary ghrelin in healthy adults, morbidly obese, and patients with metastatic carcinoma. |
| Q34589770 | Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? |
| Q37939367 | Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes. |
| Q33789529 | Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? |
| Q36292243 | Effects of bariatric surgery on glucose homeostasis and type 2 diabetes |
| Q37521930 | Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications. |
| Q37809995 | GIP and bariatric surgery |
| Q35743737 | Gastric inhibitory polypeptide (GIP) is selectively decreased in the roux-limb of dietary obese mice after RYGB surgery |
| Q26995199 | Ghrelin and eating disorders |
| Q34026487 | Ghrelin and metabolic surgery |
| Q37105254 | Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes |
| Q38267206 | Impact of roux-en Y gastric bypass surgery on prognostic factors of type 2 diabetes mellitus: meta-analysis and systematic review |
| Q37811410 | K-cells and Glucose-Dependent Insulinotropic Polypeptide in Health and Disease |
| Q26780440 | Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review |
| Q35529693 | Mechanisms responsible for excess weight loss after bariatric surgery |
| Q37922651 | Metabolic surgery-principles and current concepts |
| Q36055375 | Physiology of weight loss surgery |
| Q38053261 | Potential mechanisms by which bariatric surgery improves systemic metabolism |
| Q43044540 | Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity |
| Q90629095 | Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study |
| Q27022123 | Relationship between gut hormones and glucose homeostasis after bariatric surgery |
| Q35327470 | Resolution of diabetes mellitus by ileal transposition compared with biliopancreatic diversion in a nonobese animal model of type 2 diabetes |
| Q35963032 | Role of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery |
| Q37862878 | Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. |
| Q64951495 | Roux-en-Y gastric bypass in rat reduces mu-opioid receptor levels in brain regions associated with stress and energy regulation. |
| Q81712168 | Surgical management of gastroesophageal reflux disease in obesity |
| Q64976609 | The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss. |
| Q42730636 | The Impact of Ghrelin in Metabolic Diseases: An Immune Perspective |
| Q37691662 | The effect of bariatric surgery on gut hormones that alter appetite |
| Q47755835 | The effects of individualized gastric electrical stimulation on food craving and gastrointestinal peptides in dogs |
| Q30388925 | The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity |
| Q46125804 | Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options |
Search more.